Asmina, Julmasida .
HRN: 23-11-46 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/25/2023
CEFUROXIME 750MG (VIAL)
05/25/2023
05/31/2023
IV
570mg
Q8
Pcap C
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes